Browsing by Subject
Mostrando ítems 1-1 de 1
-
Early Reduction of MRI Activity During 6 Months of Treatment With Cladribine Tablets for Highly Active Relapsing Multiple Sclerosis
(Lippincott Williams & Wilkins, 2022-07)
Mostrando ítems 1-1 de 1